Differential Expression of Nuclear 11β-Hydroxysteroid Dehydrogenase Type 2 in Mineralocorticoid Receptor Positive and Negative Tissues

Corticosteroid hormone action is controlled at a pre-receptor level by the activity of two isoforms of 11β-hydroxysteroid dehydrogenase (11β-HSD), catalyzing the interconversion of hormonally active cortisol to inactive cortisone. In particular 11β-HSD2 protects the mineralocorticoid receptor (MR) from glucocorticoid excess, enabling aldosterone to interact with the MR. We have analyzed the subcellular localization of 11β-HSD2 in relation to the expression of the MR in human colon and placenta. 3H-aldosterone binding studies confirmed expression of the MR in human colon but not term placental trophoblast. Enzyme activity studies and Western blot analyses carried out on subcellular fractions confirmed the presence of 11β-HSD2 in microsomes. In colon, but not placenta, 11β-HSD2 was also localized to the microsome-free, nuclear fraction. Protection upon the MR by 11β-HSD2 in “classical” mineralocorticoid target tissues such as colon can be subserved at both a nuclear and extra-nuclear level. Tissue specific factors are responsible for the subcellular localization of 11β-HSD2 and we postulate that one such factor may be the MR itself.